Mr. Speaker, we have always tried to find that correct balance between protecting our innovators and also ensuring that Canadians continue to have an affordable source for the drugs they need. We continue to consult with the provinces and territories to ensure that the best interests of Canadians are reflected in the Canada-EU trade negotiations. These negotiations have been, and continue to be, the most open and transparent in Canada's history.
I will remind the House that we are committed to signing an agreement only if it is in the best interests of Canadians.